Christina Dahl

机构：Cancer Institute (WIA), Danish Cancer Society · ORCID：0000-0002-6177-2640

发表论文 85 篇 · 总被引 2843 次 · h-index 24

代表论文

• Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial (2018 · The Lancet Haematology · 被引 156)
• KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study (2019 · Haematologica · 被引 140)
• DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies (2019 · International Journal of Molecular Sciences · 被引 72)
• Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells (2018 · Nature Communications · 被引 52)
• Simultaneous Profiling of DNA Mutation and Methylation by Melting Analysis Using Magnetoresistive Biosensor Array (2017 · ACS Nano · 被引 45)
• BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients (2022 · Clinical Epigenetics · 被引 24)